24/7 Wall St.42d agoneutral
Eli Lilly Just Won FDA Approval for a Once Weekly Insulin and the Stock Is Knocking on $1,200News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
107last 24h
3126last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.69d agoneutral
Eli Lilly (LLY) Stock May Be 30% Undervalued Despite Fresh FDA ApprovalThe Wall Street Journal76d agoneutral
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli LillyBioPharma Dive108d agoneutral
Lilly, with new data, to seek FDA approval of obesity drug retatrutideInsider Monkey144d agoneutral
FDA Approves New Eight-Week Maintenance Dosing Regimen for Eli Lilly’s (LLY) EBGLYSS